Current liabilities increased 32.6%
Current liabilities changed +32.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Current liabilities changed +32.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Total assets changed +64.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current assets changed +29.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Inventory changed +40.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Working capital / assets changed -1127 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Operating margin changed -575 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Working capital changed +27.2% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Gross margin changed -902 basis points from the comparable as-filed period.
Cost of revenue changed +83.4% from the comparable as-filed period.
SBC / revenue changed -324 basis points from the comparable as-filed period.
Capex / revenue changed +382 basis points from the comparable as-filed period.
Revenue changed +16.7% from the comparable as-filed period.
Cash & equivalents changed +17.7% from the comparable as-filed period.
Stock-based compensation changed -26.9% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Capital expenditure changed +475.1% from the comparable as-filed period.
Receivables / revenue changed -284 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating income changed -6.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Free-cash-flow proxy changed -13.4% from the comparable as-filed period.
Inventory / revenue changed +123 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Research & development changed +13.9% from the comparable as-filed period.
Free-cash-flow margin changed -646 basis points from the comparable as-filed period.
Operating cash flow changed +4.9% from the comparable as-filed period.
Operating cash-flow margin changed -264 basis points from the comparable as-filed period.
Trade receivables changed +12.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Shares outstanding changed +1.4% from the comparable as-filed period. The change ranks at the 0th percentile of 8 prior comparable changes.
Selling, general & administrative changed +6.2% from the comparable as-filed period.
R&D / revenue changed -71 basis points from the comparable as-filed period.
Current ratio changed -2.5% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Operating margin changed +2002 basis points from the comparable as-filed period.
Revenue changed +66.9% from the comparable as-filed period.
Gross margin changed -475 basis points from the comparable as-filed period.
Cash & equivalents changed +53.4% from the comparable as-filed period.
Stockholders' equity changed +440.4% from the comparable as-filed period.
Trade receivables changed +60.9% from the comparable as-filed period.
Cost of revenue changed +110.0% from the comparable as-filed period.
Working capital changed +32.6% from the comparable as-filed period.
Research & development changed +27.7% from the comparable as-filed period.
SBC / revenue changed -772 basis points from the comparable as-filed period.
Current assets changed +26.8% from the comparable as-filed period.
Operating income changed +1528.7% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Total assets changed +21.7% from the comparable as-filed period.
Inventory changed +35.5% from the comparable as-filed period.
R&D / revenue changed -983 basis points from the comparable as-filed period.
Stock-based compensation changed -22.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Receivables / revenue changed -260 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Current liabilities changed +16.3% from the comparable as-filed period.
Inventory / revenue changed -174 basis points from the comparable as-filed period.
Working capital / assets changed +459 basis points from the comparable as-filed period.
Current ratio changed +9.1% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Shares outstanding changed +2.1% from the comparable as-filed period. The change ranks at the 12th percentile of 8 prior comparable changes.
Selling, general & administrative changed +7.6% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.